Congenital malformations of nose

Q17_CONGEN_MALFO_NOSE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q30 Cause of death: ICD-10 — Q30 2 out of 7 registries used, show all original rules.	59
4. Check minimum number of events None	59
5. Include endpoints None	59
6. Filter based on genotype QC (FinnGen only)	59

Control definitions (FinnGen only)

Control exclude: Q17_CONGEN_MALFO_RESPI_SYSTEM

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q3[0-4]
Name in latin: Malformationes congenitae nasi

NAME	Q17_CONGEN_MALFO_NOSE
CONTROL_EXCLUDE	Q17_CONGEN_MALFO_RESPI_SYSTEM
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q30
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q30
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Congenital malformations of nose based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	653	364	284
Only index persons	530	302	228
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	22.66	24.80	19.44
Only index persons	28.41	31.22	24.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	59	39	20
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	36.05	40.04	28.28

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
54: Matched controls
539

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q30.8

ICD-10 Finland

Other congenital malformations of nose

+∞

23.7

DLD00

NOMESCO Finland

Reconstruction of cartilage of nose

+∞

14.2

Q30.9

ICD-10 Finland

Congenital malformation of nose, unspecified

+∞

14.2

DLD20

NOMESCO Finland

Rhinoplasty

+∞

10.8

Q30.0

ICD-10 Finland

Choanal atresia

+∞

10.8

J34.2

ICD-10 Finland

Deviated nasal septum

18.3

9.3

DLD10

NOMESCO Finland

Reconstruction of cartilage and bone of nose

+∞

7.5

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

78.8

6.6

Q30.3

ICD-10 Finland

Congenital perforated nasal septum

+∞

6.4

ZZG00

NOMESCO Finland

Graft of cartilage

+∞

6.4

UDH02

NOMESCO Finland

Rhinopharyngoscopy

13.3

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

3.36

1.9

1.4

—

(3022145) Colonoscopy Study observation

2.99

2.34

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

5.34

2.11

2.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

5.34

2.11

1.6

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.22

1.62

2.5

—

(42870588) Differential panel, method unspecified - Blood

164

1.91

1.56

6.6

8.1

—

(3000494) Fungus identified in Specimen by Culture

2.26

1.51

2.7

2.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

3.11

1.39

1.4

1.3

—

(3022313) Gas panel - Capillary blood

2.66

1.34

5.7

11.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2.94

1.31

6.0

23.6

1.11

1.12

mg/l

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2.41

1.30

6.0

5.5

1.93

1.66

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.78

1.24

1.6

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

105

1.87

1.23

3.7

2.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

211

1.74

1.23

16.6

7.3

1.21

mmol/l

0.05

179

(3026008) Bacteria identified in Urine by Culture

115

1.81

1.17

3.6

2.6

—

(3019225) pH of Specimen

2.51

1.17

18.3

4.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.39

1.05

2.2

2.0

—

(3012516) Albumin [Mass/volume] in Urine

1.78

0.99

6.0

2.5

12.24

22.54

mg/l

—

(40768804) Tissue Pathology biopsy report

184

1.62

0.97

2.1

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

139

1.66

0.96

3.5

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.84

0.94

2.9

2.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1.75

0.87

1.3

1.5

22.42

19.40

nmol/l

0.38

(3030467) Casts [#/volume] in Urine by Automated count

125

1.63

0.86

3.8

3.6

0.03

0.51

e6/l

2.16

(3000330) Specific gravity of Urine by Test strip

0.00

0.81

0.0

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2.09

0.74

2.2

4.6

10.20

69.55

u/ml

—

(3020682) Albumin/Creatinine [Ratio] in Urine

104

1.59

0.71

6.7

3.2

2.95

3.87

mg/mmol

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.93

0.70

1.0

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.93

0.70

2.8

10.9

26.00

24.30

mmol/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

172

0.62

0.70

7.0

3.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1.65

0.64

3.1

3.0

2255.80

217.82

ng/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

123

0.60

0.63

6.4

4.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

121

0.61

0.63

5.6

2.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.61

0.0

1.3

—

(3015736) pH of Urine

189

0.66

0.61

5.2

3.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.61

0.0

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

0.61

0.0

2.7

—

59.44

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.74

0.59

2.3

3.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.69

0.57

15.2

14.8

26.27

25.28

mmol/l

—

(3042936) Bacteria identified in Isolate by Culture

1.62

0.57

2.1

—

(3000991) Gas panel - Venous blood

1.64

0.56

24.0

12.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

496

0.67

0.51

18.2

12.6

25.00

20.57

mg/l

0.33

358

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

149

1.41

0.50

7.1

3.8

—

(3023368) Bacteria identified in Blood by Culture

1.47

0.49

7.1

4.8

—

(40758558) Short blood count panel - Blood

141

1.40

0.48

3.0

8.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.50

0.47

3.0

2.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

453

1.48

0.46

4.3

3.9

5.74

mmol/l

0.01

423

(1761868) Lipid panel - Serum or Plasma

179

0.71

0.44

2.9

2.4

—

(3002582) Erythrocytes [#/volume] in Urine

134

1.38

0.43

6.9

3.6

8.38

26.62

e6/l

0.92

106

(36304419) Bacteria [Presence] in Urine

125

1.38

0.43

4.0

3.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.38

0.42

2.0

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.42

0.0

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.42

0.0

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.42

0.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.42

0.0

1.3

—

60.79

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

424

1.39

0.40

13.0

9.8

88.55

89.44

ml/min/173m2

0.09

332

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.36

0.39

3.1

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

416

0.76

0.39

5.3

4.4

39.91

38.31

mmol/mol

0.39

394

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.51

0.37

1.7

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.42

0.35

1.8

3.1

2.45

2.43

mmol/l

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

196

1.28

0.34

3.1

3.0

86.53

93.68

ug/l

0.13

186

(3019832) Treponema pallidum Ab [Presence] in Serum

1.28

0.31

1.7

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

144

1.25

0.26

1.9

1.8

90.44

92.01

pmol/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

116

1.27

0.25

3.9

7.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

248

0.82

0.24

12.8

5.5

6.69

6.47

mmol/l

0.11

229

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.27

0.23

4.0

1.4

—

(4010399)

1.21

0.22

1.4

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.21

0.0

3.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.2

—

(1616796) Gas panel - Central venous blood

0.00

0.21

0.0

8.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.6

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.21

0.0

1.2

—

(3000492) Spirometry study

1.31

0.21

1.0

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.31

0.21

1.3

1.8

—

(3012544) pH of Venous blood

1.28

0.21

12.7

7.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.21

0.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.25

0.21

1.3

1.8

—

(3002032) Base excess in Venous blood by calculation

1.25

0.21

12.7

7.2

2.23

2.42

mmol/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

110

1.23

0.19

2.7

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.20

0.17

2.1

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

503

1.28

0.16

16.5

13.5

71.98

69.46

umol/l

0.42

503

(3037467) Urinalysis macro (dipstick) panel - Urine

321

0.87

0.16

7.1

4.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.83

0.15

1.4

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

212

1.14

0.13

4.8

4.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

454

1.17

0.12

4.1

3.9

1.50

1.52

mmol/l

0.06

425

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

105

1.18

0.12

1.8

2.3

0.81

0.78

mg/l

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.15

0.10

2.8

7.5

6.06

5.15

kpa

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.10

0.09

6.2

9.0

—

(3013512) EKG study

117

1.14

0.09

3.0

2.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1.08

0.09

1.8

2.0

56.83

28.70

u/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.04

0.08

3.5

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.10

0.07

2.1

1.5

—

(3021589) Normoblasts [#/volume] in Blood

229

1.08

0.05

8.5

10.0

0.00

e9/l

0.00

183

(3044889) 12 lead EKG panel

309

1.08

0.05

2.4

3.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

150

1.09

0.05

3.1

3.2

13.40

23.76

ng/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

131

1.09

0.04

1.9

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

462

1.09

0.03

4.3

4.4

3.22

2.88

mmol/l

1.36

433

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

409

1.01

0.00

3.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

474

0.96

0.00

15.2

13.3

40.44

40.59

0.06

376

(3007164) IgA [Mass/volume] in Serum or Plasma

134

0.96

0.00

2.4

1.6

2.16

2.09

g/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

442

0.98

0.00

4.1

3.6

1.22

1.23

mmol/l

0.04

412

(40761511) CBC panel - Blood by Automated count

515

1.08

0.00

11.9

9.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

4.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

0.0

2.8

—

21.60

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

7.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

3.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

1.91

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

285.40

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

2.4

—

6.51

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

2.3

—

(44806118)

0.00

0.0

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

21.2

—

2195.67

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

2.3

—

4.07

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.0

1.0

—

(3003694) ABO and Rh group [Type] in Blood

130

1.00

0.00

1.4

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

6.6

—

197.14

—

(4027681)

0.00

0.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

3.0

—

0.48

—

(3002256) Pathology report gross observation

0.91

0.00

1.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(44790048)

0.00

0.0

1.4

—

(44790047)

0.00

0.0

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

1.5

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

9.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

1.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

2.1

—

769.29

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.3

—

(44790049)

0.00

0.0

1.4

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.7

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

18.0

—

1065.50

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

2.6

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

2.2

—

1.26

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.0

2.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

259.67

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

2.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

2.3

—

108.67

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_MALFO_NOSE and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_NOSE.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_MALFO_NOSE – Congenital malformations of nose

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Congenital malformations of nose

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints